Arieli Capital Accepts BlueGate Offer for 58% Controlling Stake in Elron

Arieli EL has accepted BlueGate Capital's offer to acquire its 58 percent stake in Elron at a 100 percent market premium, allowing it to clear debt with Phoenix Holdings and exit with millions in profit.

Arieli Capital Accepts BlueGate Offer for 58% Controlling Stake in Elron
Photo: Phoenix Insurance Company / Wikimedia Commons

Arieli EL, the controlling shareholder of Elron, has accepted an acquisition offer from BlueGate Capital—backed by New York’s Melnik family—to purchase its 58 percent controlling stake in the company at a 100 percent premium over the market price on the day of the proposal. Although the tender offer is not directed at public shareholders, Elron shares surged 17 percent, bringing total gains to 30 percent since the offer was received. The company is currently traded at a valuation of 257 million shekels.

The transaction enables Arieli EL to repay a 90 million shekel debt taken from Phoenix Holdings to finance the acquisition of Elron's controlling stake in July 2024. Following a decline in the company share price, Arieli EL failed to meet the loan covenants, prompting Phoenix Holdings to push for early repayment. Under the new agreement, Arieli EL will receive 180 million shekels, allowing the firm to settle its obligation with Phoenix while generating tens of millions of shekels in profit on its original investment.

The purchasing entity, BlueGate Capital, is funded by the Melnik family, a New York-based family with prior ties to Oren Renov, a partner at Arieli EL. BlueGate plans to appoint Micha Lukin Avni as the new chairman of Elron. Avni currently serves as CEO of non-bank credit firm Peninsula and is a former partner at Jerusalem Global Ventures as well as a former director at several high-tech firms.

Partner Disparities and Leadership Changes

Background negotiations were complicated by an escalating dispute among the partners of Arieli LM, which holds a third of Arieli Capital each alongside Oren Renov and Arik Ben-Tov on one side, and partner Lisia Becher-Manor—who was appointed by them as chairperson—on the other. The partners disagreed on how to resolve the loan crisis involving Phoenix Holdings, and the dispute escalated to the removal of Becher-Manor from her active chair position, though she remains a board member.

Elron historically focused on medical devices, software, and cybersecurity, recording notable exits including Given Imaging and CartiHeal. Under recent leadership, Becher-Manor emphasized defense-tech and cybersecurity sectors, overseeing the monetization of six holdings and twenty new investments totaling 12 million US dollars. During this period, Elron distributed approximately 30 million US dollars in dividends, with over half flowing directly to the controlling shareholder. The company is managed by Yaniv Schneider.

Related News